Literature DB >> 30246944

Monitoring Sphingolipid Trafficking in Cells using Fluorescence Microscopy.

Emma L Sundberg1, Yongqiang Deng1, Christopher G Burd1.   

Abstract

Sphingolipids are structural components of organelle membranes that also participate in signal transduction pathways. Complex sphingolipids are trafficked from their site of synthesis in organelles of the early secretory pathway to the Golgi apparatus, the plasma membrane, and the endo-lysosomal system. We have developed fluorescence microscopy-based methods to monitor sphingolipid trafficking in coordination with secretory protein sorting. A sphingomyelin binding protein fused to a fluorescent protein, which we term "EQ-SM," is implemented to monitor sphingomyelin trafficking from the Golgi apparatus to the plasma membrane via secretory vesicles. A protocol is provided to determine if a query protein of interest is secreted from the cell via vesicles enriched in EQ-SM, an indication that the vesicle membrane is enriched in sphingomyelin. A complementary protocol is described that implements a chemically modified form of sphingosine, a metabolic precursor to complex sphingolipids, to visualize ceramide and complex sphingolipids in fixed cells.
© 2018 by John Wiley & Sons, Inc. © 2018 John Wiley & Sons, Inc.

Entities:  

Keywords:  Golgi apparatus; click chemistry; equinatoxin; fluorescence microscopy; pacSphingosine; secretion; sphingolipid; sphingomyelin

Mesh:

Substances:

Year:  2018        PMID: 30246944      PMCID: PMC6386611          DOI: 10.1002/cpcb.67

Source DB:  PubMed          Journal:  Curr Protoc Cell Biol        ISSN: 1934-2616


  2 in total

1.  Syndecan-1 Mediates Sorting of Soluble Lipoprotein Lipase with Sphingomyelin-Rich Membrane in the Golgi Apparatus.

Authors:  Emma L Sundberg; Yongqiang Deng; Christopher G Burd
Journal:  Dev Cell       Date:  2019-09-19       Impact factor: 12.270

2.  Sorting and Trafficking in the Endo-Lysosomal System: An Interview with Chris Burd, PhD.

Authors:  Jingyao Qiu
Journal:  Yale J Biol Med       Date:  2019-09-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.